LATEST
Open App
Agreement signedPublished 6 Oct 2023

Lynxdx, Inc. /
Biora Therapeutics, Inc.

Lynxdx to buy Biora Therapeutics property in Michigan

Buy side: Lynxdx, Inc.
Buy sideLynxdx, Inc.
Target: Biora Therapeutics, Inc.
TargetBiora Therapeutics, Inc.
Source · 6 Oct 2023
See the source
Buy side: Lynxdx, Inc.
Buy sideLynxdx, Inc.
Target: Biora Therapeutics, Inc.
TargetBiora Therapeutics, Inc.
01 / BuyerLynxdx, Inc.
02 / TargetBiora Therapeutics, Inc.
01

What happened

Biora Therapeutics, Inc. agreed to sell its Ann Arbor building and real property to Lynxdx, Inc. The property was formerly used as a genetics laboratory.

The total consideration is $2,750,000, before estimated commissions, fees and closing costs of approximately $250,000. Closing is subject to customary conditions.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Lynxdx to buy Biora Therapeutics property in Michigan

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.